Owlstone Medical Limited

1 trials Commercial sponsor

Filter these 1 trials by condition, phase, country and more.

Open in Search →
1 Registered trials
0 Recruiting
1 Completed trials
2 Countries active
1 Unique IMPs
100% Results reported
Phase II: 1
100%

1 of 1 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Large cell lung cancer recurrent 1 Adenosquamous cell lung cancer 1 Adenosquamous cell lung cancer stage II 1 Large cell lung cancer 1 Small cell lung cancer extensive stage 1 Adenosquamous cell lung cancer stage I 1 Small cell lung cancer 1 Adenosquamous cell lung cancer stage 0 1 Adenosquamous cell lung cancer stage IV 1 Large cell lung cancer stage 0 1 Adenosquamous cell lung cancer recurrent 1 Adenosquamous cell lung cancer stage III 1

Top IMPs

D5-ETHYL-BETA-D-GLUCURONIDE 1

All trials

1 total

Showing 1–1 of 1 trials

← All sponsors A–Z